Clinical Trial Update: Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial evaluates the safety and activity of a carfilzomib, pomalidomide, and dexamethasone combination in adults with relapsed or refractory multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Pomalyst (pomalidomide)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED